Literature DB >> 785942

The diagnostic value of determination of IgM antibodies against Mycoplasma pneumoniae by the indirect immunofluorescent antibody test.

K Skaug, J Eng, I Orstavik, K W Haug.   

Abstract

The indirect fluorescent antibody technique for specific IgM and IgG antibodies was applied to paired sera from 33 patients with a current M. pneumoniae infection, along with the complement fixation test. A roughly parallel increase in antibody titres in all the three tests was observed; the ratio of IgM/IgG titres was, however, higher in patients below 20 years of age than in older patients. Rises in antibody titres were regularly observed in spite of the fact that most of the patients were treated with tetracycline or erythromycin during the acute phase of the disease. Serum specimens from 15 other patients lacking clinical data of a recent M. pneumoniae infection, but with stationary complement fixation titres, all showed IgG antibodies with stationary titers and, with the exception of three patients, a negative IgM antibody test. Sera from 20 individuals lacking complement fixing antibodies were also without demonstrable IgG and IgM antibodies. Sampling of serum from 9 of the pneumonia patients was repeated. The last IgM positive sample was collected up to six months after onset of the disease and all were found to be negative in the IgM test 8 to 10 months after onset of the illness in these treated patients. The implications of these findings for the serological diagnosis of M. pneumoniae infections are discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 785942     DOI: 10.1111/j.1699-0463.1976.tb01922.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand B        ISSN: 0105-0656


  12 in total

1.  A micro-capture ELISA for detecting Mycoplasma pneumoniae IgM: comparison with indirect immunofluorescence and indirect ELISA.

Authors:  T G Wreghitt; M Sillis
Journal:  J Hyg (Lond)       Date:  1985-04

2.  The serological diagnosis of Mycoplasma pneumoniae infection: a comparison of complement fixation, haemagglutination and immunofluorescence.

Authors:  S A Rousseau; R E Tettmar
Journal:  J Hyg (Lond)       Date:  1985-10

3.  Eosinophilic Fasciitis associated with Mycoplasma arginini infection.

Authors:  Pálma Silló; Dóra Pintér; Eszter Ostorházi; Mercedes Mazán; Norbert Wikonkál; Katinka Pónyai; Dmitriy V Volokhov; Vladimir E Chizhikov; Susan Szathmary; Laszlo Stipkovits; Sarolta Kárpáti
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

4.  Age-related prevalence of complement-fixing antibody to Mycoplasma pneumoniae during an 8-year period.

Authors:  A Pönkä; P Ukkonen
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

5.  Evaluation of an indirect haemagglutination kit for the rapid serological diagnosis of Mycoplasma pneumoniae infections.

Authors:  P Taylor
Journal:  J Clin Pathol       Date:  1979-03       Impact factor: 3.411

6.  Use of the enzyme-linked immunosorbent assay for the early diagnosis of Mycoplasma pneumoniae infection.

Authors:  A J van Griethuysen; R de Graaf; J A van Druten; F W Heessen; J T van der Logt; A M van Loon
Journal:  Eur J Clin Microbiol       Date:  1984-04       Impact factor: 3.267

7.  Comparison of enzyme-linked immunosorbent assay (ELISA) and complement fixation test for detection of Mycoplasma pneumoniae antibodies.

Authors:  E Dussaix; A Slim; P Tournier
Journal:  J Clin Pathol       Date:  1983-02       Impact factor: 3.411

8.  Immunological reactions against Mycoplasma pneumoniae in multiple sclerosis: preliminary findings.

Authors:  E Maida
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

9.  Adherence inhibition assay: a specific serological test for detection of antibodies to Mycoplasma pneumoniae.

Authors:  E Jacobs; K Schöpperle; W Bredt
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

10.  Immunological response to infection with human reovirus-like agent: measurement of anti-human reovirus-like agent immunoglobulin G and M levels by the method of enzyme-linked immunosorbent assay.

Authors:  R H Yolken; R G Wyatt; H W Kim; A Z Kapikian; R M Chanock
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.